Luoxin Pharmaceuticals Group Stock Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 0.17%

Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has an Asset Resilience Ratio of 0.17% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Luoxin Pharmaceuticals Group Stock Co Lt current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥6.00 Million

≈ $877.99K USD Cash + Short-term Investments

Total Assets

CN¥3.61 Billion

≈ $528.95 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Luoxin Pharmaceuticals Group Stock Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Luoxin Pharmaceuticals Group Stock Co Lt.

Liquid Assets Composition Over Time

This chart breaks down Luoxin Pharmaceuticals Group Stock Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Luoxin Pharmaceuticals Group Stock Co Lt long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥6.00 Million	0.17%
Total Liquid Assets	CN¥6.00 Million	0.17%

Asset Resilience Insights

Limited Liquidity: Luoxin Pharmaceuticals Group Stock Co Ltd maintains only 0.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Luoxin Pharmaceuticals Group Stock Co Ltd Industry Peers by Asset Resilience Ratio

Compare Luoxin Pharmaceuticals Group Stock Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Luoxin Pharmaceuticals Group Stock Co Ltd (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Luoxin Pharmaceuticals Group Stock Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.11%	CN¥4.00 Million ≈ $585.33K	CN¥3.73 Billion ≈ $545.13 Million	+0.08pp
2024-12-31	0.03%	CN¥1.25 Million ≈ $182.96K	CN¥4.34 Billion ≈ $634.49 Million	-0.01pp
2023-12-31	0.04%	CN¥2.10 Million ≈ $307.30K	CN¥5.12 Billion ≈ $748.84 Million	-0.17pp
2022-12-31	0.21%	CN¥17.10 Million ≈ $2.50 Million	CN¥8.11 Billion ≈ $1.19 Billion	+0.08pp
2021-12-31	0.13%	CN¥12.58 Million ≈ $1.84 Million	CN¥9.50 Billion ≈ $1.39 Billion	+1.41pp
2020-12-31	-1.28%	CN¥-98.99 Million ≈ $-14.48 Million	CN¥7.72 Billion ≈ $1.13 Billion	-2.71pp
2019-12-31	1.43%	CN¥106.84 Million ≈ $15.63 Million	CN¥7.46 Billion ≈ $1.09 Billion	-4.49pp
2018-12-31	5.92%	CN¥83.04 Million ≈ $12.15 Million	CN¥1.40 Billion ≈ $205.12 Million	+5.78pp
2017-12-31	0.14%	CN¥1.30 Million ≈ $189.65K	CN¥898.93 Million ≈ $131.54 Million	+0.14pp
2016-12-31	0.00%	CN¥6.00K ≈ $877.99	CN¥812.89 Million ≈ $118.95 Million	-0.06pp
2014-12-31	0.06%	CN¥279.25K ≈ $40.86K	CN¥447.86 Million ≈ $65.54 Million	-0.53pp
2012-12-31	0.59%	CN¥2.19 Million ≈ $320.65K	CN¥372.31 Million ≈ $54.48 Million	--

pp = percentage points

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$735.27 Million

CN¥5.02 Billion CNY

Market Cap Rank

#10398 Global

#2805 in China

Share Price

CN¥4.62

Change (1 day)

+2.21%

52-Week Range

CN¥3.80 - CN¥5.77

All Time High

CN¥25.07